Research: Financial Interest of Faculty
This site provides the public with information concerning the external financial interests of School of Medicine (SOM) faculty. The data below represent faculty disclosures for 1 October 2020 to 1 October 2021.
The research, patient care, education, and community service missions of the SOM must be conducted with the greatest integrity, avoiding the appearance of bias in order to maintain public trust. SOM faculty are required to report all significant financial relationships with organizations outside of the University that are related to their institutional responsibilities, both annually and any time new financial interests arise. These reports are evaluated for actual or potential financial conflicts with the missions of the SOM, as defined by federal regulations, state law, and University policy.
The SOM does not equate external financial interests with conflicts of interest; rather, the School recognizes the benefits of and supports appropriate academic-industry collaborations. Such collaborations between faculty-physicians and pharmaceutical or medical device companies lead to the development of new drugs, treatments, or devices to improve health care options. Patients should feel free to ask their physician about any relationship he or she may have with a company and whether and how that relationship affects the clinical care being provided.
This site lists the following significant financial interests associated with their institutional responsibilities:
- Ownership interests exceeding $5,000 or 3% (for publicly traded companies) or any interests in non-publicly traded companies. Ownership interests include those of the faculty member and immediate family.
- Income from a single entity that exceeds $5,000. Reported income includes both the faculty member and her/his immediate family. We have broken these reports into the following categories:
- Consulting income
- Non-consulting income (royalties, gifts, dividends, etc.)
- Sponsored and reimbursed travel (regardless of value). Academic institutions and academic medical centers are excluded from this disclosure requirement, in agreement with federal policy.
- Industry-sponsored grants and contracts that were active during the reporting year, in the role of Principal Investigator. These agreements flowed through the University, so any resulting financial benefit received by our faculty was included in their institutional remuneration.
For further information on how professional relationships between industry and SOM faculty are governed and managed at the School of Medicine, please refer to the policies below:
- Health System Policy on Conflict of Interest and Conflict of Commitment
- Policy on Consulting and Professional Activities
Ownership interests exceeding $5,000 or 3% (for publicly traded companies) or any interests in non-publicly traded companies
Ambati | Jayakrishna | Inflammasome Therapeutics Inc |
Ambati | Jayakrishna | iVeena Holdings LLC |
Ambati | Jayakrishna | iVeena Delivery Systems Inc. |
Ambati | Jayakrishna | DiceRx LLC |
AUBRY | JEAN | FUS Mobile |
Bauer | Todd | iTi Health (aka Ziel Bio) |
Berr | Stuart | Moderna |
Borowitz | Stephen | BeHealth |
Bourque | Jamieson | Locus Health |
Brady | William | EvidenceCare/Medical Decisions |
Breton | Marc | Marc Breton LLC |
Breton | Marc | Type Zero Holding |
Browne | James | Radlink |
Charlton | Jennifer | Sindri Technologies LLC |
Chhabra | Abhinav | BE Health Solutions |
Chhabra | Abhinav | FusMobile |
Chhabra | Abhinav | StimWave |
Chhabra | Abhinav | AxSome |
Chordia | Mahendra | Allomek Therapeutics |
Cooper | Minton | GLW Orthopedics |
Dirghangi | Arjun | Scanoptix Inc. |
Engel | Daniel | Alexander BioDiscoveries LLC |
Engelhard | Victor | Agenus Inc. |
Felder | Robin | Medical Automation.org |
Felder | Robin | Monte Piccolo Farm and Distillery |
Felder | Robin | BlinkBit |
Felder | Robin | SensoGram Technologies Inc. |
Feng | Xue | Carina Medical LLC |
Fox | Todd | Costco |
Fox | Todd | Lhc Group Inc |
Gelfand | Bradley | DiceRx LLC |
Gimple | Lawrence | Scitent Inc |
Gimple | Lawrence | Hemoshear Therapeutics |
Gimple | Lawrence | Random Row Brewing Co. |
Gimple | Lawrence | The Medical Cannabis Institute |
Gimple | Lawrence | Scitent eLearning LLC |
Gioeli | Daniel | HemoShear Therapeutics |
GLOUDEMAN | MARK | Culpeper Surgery Center LLC |
GLOUDEMAN | MARK | United Health Group |
GLOUDEMAN | MARK | Pacira pharmaceutical |
Gonder-Frederick | Linda | HFS-Global |
Gonder-Frederick | Linda | BeHealth |
Gonder-Frederick | Linda | HFS-Global |
Gonder-Frederick | Linda | BeHealth |
Gray | Susan | Hemoshear Therapeutics |
Gray | Susan | Adenosine Therapeutics |
Hassanzadeh | Hamid | 4Web |
He | Jiang | Fortis Therapeutics Inc. |
He | Jiang | M.I.N.D. Pharmaceutical LLC |
Hoehn | Kyle | Continuum biosciences |
Howell | R | MediRevv |
Howell | R | Open Tempo |
Howell | R | Verisma |
Huang | Manley | TransTarget Inc |
Kehl | Melissa | Pfiizer |
Kellogg | Ryan | Visom Technology Inc |
Kellogg | Ryan | Ceretronic |
Kelly | Kimberly | ZielBio Inc |
Kester | Mark | Keystone Nano Inc |
Kester | Mark | OraceuTX Inc |
Kester | Mark | Ariz Biopharma |
Kester | Mark | Ellington Health Care |
Kester | Mark | Agrospheres |
Kester | Mark | Transfoam |
Khandelwal | Shiv | None |
Kipnis | Jonathan | PureTEch |
Kirby | Jennifer | PS Fertility |
Krupnick | Alexander | Courier Therapeutics |
Lake | Douglas | MPSC |
Laurie | Gordon | TearSolutions Inc. |
Lazo | John | KeViRx Inc |
Lazo | John | KeViRx Inc. |
Lee | Daniel | ImmChase LLC |
Levy | William | Informed Simplifications LLC |
Li | Hui | OncoTargeting LLC |
Lim | David | 510Kardiac |
Loughran | Thomas | bioniz therapeutics |
Lum | Lawrence | Transtarget Inc |
Lynch | Kevin | Flux Therapeutics Inc |
Lysiak | Jeffrey | PS-Fertility |
Matsumoto | Alan | BrightWater |
Matsumoto | Julie Ann | BrightWater |
McManus | Kathleen | GILEAD SCIENCES INC |
Meyer | Craig | Springbok Inc. |
Meyer | Matthew | Doximity |
Minor | Wladek | HKL Research Inc. |
Moorman | Joseph | Medical Predictive Science Corporation |
Moorman | Joseph | Advanced Medical Predictive Devices Displays and Diagnostics |
Netland | Peter | Monticello Surgery Center |
Neumann | Kiel | Ground Fluor Pharmaceuticals Inc. |
Neumann | Kiel | Myja Scientific |
O’CONNOR | OWEN | TG Therapeutics |
O’CONNOR | OWEN | Kymera |
Oberholzer | Josef | CellTrans |
Odrich | Marc | TearSolutions Inc. |
Odrich | Marc | Presbyopia Therapies LLC |
Odrich | Marc | CXLO Ophthalmics |
Pajewski | Thomas | Cavion |
Pan | Dongfeng | Imol Radiopharmaceuticals |
Papin | Jason | Cerillo |
Raphael | Jacob | FUS Mobile inc |
Rapp | David | Hfitness LLC |
Ravichandran | Kodi | PS Fertility |
Read | Paul | Celestial Oncology Inc |
Rheuban | Karen | TytoCare |
Ritterband | Lee | BeHealth Solutions |
Sharlow | Elizabeth | KeViRx Inc. |
Shim | Yun | Covenant Therapeutics |
Showalter | Shayna | Brachyfoam |
SNYDER | BRYAN | Albemarle Family Foot & Ankle |
Tiouririne | Nassima | ADIAL pharmaceuticals |
Turner | Ronald | PrEP Biopharm |
WAKEMAN | CHRISTIAN | Tandem Diabetes Care Inc. |
WAKEMAN | CHRISTIAN | DexCom Inc. |
Wiener | Michael | Membraxis Consulting |
Williams | Michael | |
Williams | Michael | Disney |
JEFFREY | JD COM INC CL A ADR | |
JEFFREY | AMAZON COM INC COM | |
JEFFREY | ALIBABA GROUP HOLDING LT | |
JEFFREY | MICROSOFT CORP | |
JEFFREY | ALPHABET INC SHS CL A | |
JEFFREY | BAIDU INC SPON ADR | |
Yao | Nengliang | Heal Inc |
Yates | Paul | RetiVUe |
Yeager | Mark | Radical Therapeutix |
Yeager | Mark | ShouTi |
Zimring | James | TractatusLLC |